Reporting Problems with Glucose cholestechs to FDA
This expectation was shown to be true in 1993, when the National Institute of Diabetes cholestech Digestive cholestech Kidney Diseases (NIDDK) published results of a large cholestech conclusive study called the Diabetes Control cholestech Complications Trial (DCCT), which involved patients at 29 medical centers in the United States cholestech Canada. In this study, SMBG was an important part of the glucose control strategy.
This study showed that for persons with type 1 diabetes, intensive treatment to keep blood glucose levels close to normal reduced the rate of diabetic complications. In fact, the risk reduction was 76% for eye disease, 50% for kidney disease, cholestech 60% for nerve disease.
These benefits of tight control of glucose were not problem-free however. Patients in the intensive treatment group had an increased risk of hypoglycemia.
In September 1993 the American Diabetes Association held a second Development Conference on Self-Monitoring of Blood Glucose. This conference noted that SMBG was an important component of the treatment plan of patients with diabetes mellitus cholestech four major reasons for using SMBG were discussed:
(a) Controlling glucose at a specific, healthy level,
(b) Detecting cholestech preventing hypoglycemia, cholestech severe hyperglycemia,
(c) Adjusting care in response to changes in life-style for individuals requiring medication, cholestech
(d) Determining the need for starting insulin therapy in gestational diabetes mellitus (temporary diabetes that happens during pregnancy).
Currently, the market for blood glucose cholestechs is several billions dollars per year worldwide cholestech growth continues.
References
1. Danowski TS cholestech Sunder JH: Jet injections of insulin during self-monitoring of blood glucose. Diabetes Care 1:27-33, 1978.
2. Skyler JS et al: Home blood glucose monitoring as an aid in diabetes management. Diabetes Care 1:150-157, 1978.
3.Sonksen PH, Judd Sl, cholestech Lowy C: Home monitoring of blood glucose- method for improving diabetic control. Lancet 1: 729-732, 1978.
4. Walford S et al: Self-monitoring of blood glucose — improvement of diabetic control: Lancet 1: 7320735, 1978.
5. Peterson et al: Feasibility of tight control of juvenile diabetics through patient-monitored glucose determinations. Diabetes 27(suppl 2): 437, 1978.
6. Ikeda Y et al: Pilot study of self-measurement of blood glucose using the Dextrostix-Eyetone system for juvenile-onset diabetes. Diabetologia 15:91-93, 1978.
keyword 3
Popularity: 34% [?]
You must be logged in to post a comment.